Encompass Health Corp EHC.N reported quarterly adjusted earnings of $1.40 per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $1.11. The mean expectation of twelve analysts for the quarter was for earnings of $1.21 per share. Wall Street expected results to range from $1.14 to $1.31 per share.
Revenue rose 12% to $1.46 billion from a year ago; analysts expected $1.43 billion.
Encompass Health Corp's reported EPS for the quarter was $1.39.
The company reported quarterly net income of $142.1 million.
Encompass Health Corp shares had fallen by 11.5% this quarter and gained 17.5% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 0.2% in the last three months.
In the last 30 days, there have been no negative revisions of earnings estimates
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 13 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the healthcare facilities & services peer group is also "buy"
Wall Street's median 12-month price target for Encompass Health Corp is $130.00, about 15.8% above its last closing price of $109.50
This summary was machine generated from LSEG data August 4 at 09:51 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)